D
Climb Bio, Inc. CLYM
$5.02 $0.112.24% NASDAQ
Recommendation
Prev Close
$5.02
Volume
619,316
Avg Vol (90D)
1,111,476
Market Cap
$239.68M
Dividend & Yield
--
52-Week Range
$1.05 - $5.19
P/E (TTM)
--
EPS (TTM)
-$0.76
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Climb Bio, Inc. (NASDAQ:CLYM) Short Interest Update
1/19/2026 - MarketBeat
Climb Bio, Inc. (NASDAQ:CLYM) Short Interest Update
1/19/2026 - Ticker Report
Climb Bio (CLYM, $4.22) Stochastic Oscillator left the oversold zone on January 16, 2026
1/17/2026 - Tickeron - Stocks
Climb Bio (CLYM, $3.77) Stochastic Oscillator left the oversold zone on January 15, 2026
1/16/2026 - Tickeron - Stocks
Analysts Are Bullish on Top Healthcare Stocks: Climb Bio (CLYM), Travere Therapeutics (TVTX)
1/14/2026 - TipRanks Financial Blog
Climb Bio (CLYM, $4.7) entered Downtrend as Momentum indicator drops below 0 level on Jan 12, 2026
1/13/2026 - Tickeron - Technical Analysis
Climb Bio, Inc. (NASDAQ:CLYM) Receives Average Recommendation of "Moderate Buy" from Brokerages
1/12/2026 - MarketBeat
Climb Bio (CLYM, $4.58) Stochastic Oscillator left the oversold zone on January 08, 2026
1/9/2026 - Tickeron - Technical Analysis
Climb Bio's CLYM116 Moves Into First-in-Human Testing: What Early Investors Should Watch
1/9/2026 - TipRanks Financial Blog
Wall Street Analysts Are Bullish on Top Healthcare Picks
1/8/2026 - TipRanks Financial Blog
Climb Bio (NASDAQ:CLYM) Director Purchases $24,888.50 in Stock
1/8/2026 - MarketBeat
Climb Bio announces pipeline progress, priorities for FY26
1/8/2026 - The Fly
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
1/8/2026 - GuruFocus
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
1/8/2026 - Globe Newswire
Climb Bio (NASDAQ:CLYM) Director Purchases $24,888.50 in Stock
1/7/2026 - MarketBeat
Climb Bio (CLYM, $3.75) Moving Average Convergence Divergence (MACD) Histogram turned negative on January 2, 2026
1/3/2026 - Tickeron - Stocks
Climb Bio (CLYM, $3.75) Stochastic Oscillator left the oversold zone on January 02, 2026
1/3/2026 - Tickeron - Stocks
Climb Bio (CLYM, $4) entered Downtrend as Momentum indicator drops below 0 level on Dec 31, 2025
1/1/2026 - Tickeron - Stocks
H.C. Wainwright Forecasts 2026 Data Readouts for Climb Bio's (CLYM) Budoprutug Across Clinical Tracks
12/31/2025 - Yahoo! Finance: News
Climb Bio initiated with a Buy at Freedom Capital
12/30/2025 - TipRanks Financial Blog
Climb Bio initiated with bullish view at Freedom Capital, here's why
12/30/2025 - The Fly
10 Best Biotech Penny Stocks to Buy According to Analysts
12/29/2025 - Insider Monkey
Retail investors in Climb Bio, Inc. (NASDAQ:CLYM) are its biggest bettors, and their bets paid off as stock gained 15% last week
12/28/2025 - Simply Wall St
HC Wainwright Reduces Earnings Estimates for Climb Bio
12/22/2025 - MarketBeat
HC Wainwright & Co. Raises Climb Bio (CLYM) Price Target to $11.00 CLYM Stock News
12/18/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$25.52M
EBIT (TTM)
-$59.50M
Net Income (TTM)
-$50.75M
Balance Sheet
Total Assets (Q)
$182.30M
Total Debt (Q)
$580.00K
Total Liabilities (Q)
$5.30M
Book Value Per Share (Q)
$2.60
Cash Flow
Cash from Operations (TTM)
-$44.24M
Cash from Investing (TTM)
-$76.11M
Cash from Financing (TTM)
$41.00K
Net Change in Cash (TTM)
-$120.37M
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Loading...
Beta
-0.34
7-Day Total Return
26.77%
30-Day Total Return
141.35%
60-Day Total Return
141.35%
90-Day Total Return
149.75%
Year to Date Total Return
33.87%
1-Year Total Return
177.35%
2-Year Total Return
68.46%
3-Year Total Return
41.81%
5-Year Total Return
--
52-week Low
Apr 07, 2025 - $1.05
52-week High
Jan 09, 2026 - $5.19
Valuation
Market Cap
$239.68M - Micro Cap
Enterprise Value
$64.43M
Price/Sales (TTM)
--
Price/Book (Q)
1.93
Dividends and Shares
Shares Outstanding
68.00M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
climbbio.com
Phone Number
866 857 2596
Address
20 William Street
Wellesley Hills, MA 02481
Country
United States
Year Founded
2018
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases. The company develops budoprutug, an anti-CD19 monoclonal antibody for the... more
NASDAQ 01/23/2026 4:00PM Eastern Quotes delayed